| Fiscal Year End | Company Status | Exempt Flag |
| August 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 12/Jun/2007 | 10/Apr/2016 | Canada | | continued to province of BC under BC Business Corporations Act |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Biotechnology/Biopharmaceutical
| News Release November 7, 2014 - Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX VENTURE: KLH) is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, Alzheimer's, and inflammatory diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology. We are committed to meeting the growing demand for commercial-scale supplies of GMP grade KLH, ensuring environmentally sound KLH production, and developing KLH-based active immunotherapies.
|
|
| *Capital Pool Company
| (not available)
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *KLH | *Stellar Biotechnologies, Inc. | TSX Venture | DELIST |
| *KLH | *Stellar Biotechnologies, Inc. old | TSX Venture | DELIST |
| *CAG.P | *CAG Capital Inc | TSX Venture | DELIST |
|
|
| Name History | From | To |
| *Stellar Biotechnologies, Inc. | 19/Apr/2010 | 10/Apr/2016 |
| *CAG Capital Inc. | 18/Jul/2008 | 18/Apr/2010 |
| *China Growth Capital Inc. | 14/Dec/2007 | 17/Jul/2008 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
